Gary W. Small, MD, Chair of Psychiatry, Hackensack University Medical Center, Behavioral Health Physician in Chief, Hackensack Meridian Health, Hackensack, New Jersey.
J Fam Pract. 2022 Jul;71(6 Suppl):S82-S87. doi: 10.12788/jfp.0374.
At the end of the activity, participants will be able to:Implement evidence-based methods for cognitive impairment screening in primary care. Identify correct diagnostic criteria for mild cognitive impairment (MCI) and Alzheimer disease (AD) based on current guideline recommendations. Design appropriate and effective treatment plans for patients with MCI and AD and refer to a specialist when necessary. Describe advances in testing and treatment for AD that may impact dementia care.
在活动结束时，参与者将能够：
在初级保健中实施基于证据的认知障碍筛查方法。
根据当前指南建议，确定轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 的正确诊断标准。
为 MCI 和 AD 患者设计适当且有效的治疗计划，并在必要时转介给专家。
描述 AD 测试和治疗的进展，这些进展可能会影响痴呆症护理。
